Published in Cancer Weekly, July 29th, 1996
Americans have spent about $400 million testing for radon and renovating homes with high levels. But experts said that several studies suggest the minimum residential level of the gas that poses a significant cancer risk is not known.
The study, conducted in Finland, analyzed residential exposure to radon for 1,055 lung cancer patients and compared that with the radon exposure of 1,544 people without lung cancer. Researchers at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.